GILD - Company ID 0000882095
The table below shows GILEAD SCIENCES, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $29.44B | $28.75B | $27.12B | $27.28B | $27.30B | $24.69B |
| Cost of revenue | $6.23B | $6.25B | $6.50B | $5.66B | $6.60B | $4.57B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
GILEAD SCIENCES, INC. reported annual revenue of $29.44B for fiscal year 2025. That is up 2.4% from $28.75B in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $30.39B (FY 2016) to $29.44B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $5.77B |
| $6.09B |
| $6.09B |
| $5.67B |
| $5.25B |
| $5.15B |
| Operating income | $10.02B | $1.66B | $7.61B | $7.33B | $9.92B | $4.07B |
| Income tax | $1.29B | $211.00M | $1.25B | $1.25B | $2.08B | $1.58B |
| Net income | $8.51B | $480.00M | $5.67B | $4.59B | $6.22B | $123.00M |
| EPS (diluted) | $6.78 | $0.38 | $4.50 | $3.64 | $4.93 | $0.10 |